SCHEMBL21390936

SCHEMBL21390936

CC(C)(C)CC(=O)CCCc1nc2c(F)cc(C#N)cc2n1C(C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21391082 0.86
SCHEMBL21390885 0.85 AR (0.32)
SCHEMBL21391062 0.84 ACSS2 (0.33)
SCHEMBL23132029 0.83 HDAC1 (0.33)
SCHEMBL21390794 0.81
SCHEMBL21390935 0.80 HDAC1 (0.33)
SCHEMBL21390889 0.77
SCHEMBL21354647 0.76 KCNQ3 (0.35)
SCHEMBL21391177 0.74 RORC (0.32)
SCHEMBL21391032 0.74

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2021055538-A1 METHODS OF USE FOR KV7 CHANNEL ACTIVATORS KNOPP BIOSCIENCES LLC (US) 2021-03-25 WO disclosed
WO-2019183148-A1 KV7 CHANNEL ACTIVATORS COMPOSITIONS AND METHODS OF USE KNOPP BIOSCIENCES LLC (US) 2019-09-26 WO disclosed